eMed Scoops Up $200M at $2B+ Valuation

EMed announced a funding round raised $200 million at a valuation above $2 billion.

EMed program reported member adherence rates achieved more than 90% member adherence.

Reported average weight loss among participants average weight loss of 21 pounds.

Reported biomarker improvement 99% saw improvement in at least one key biomarker within six months.

EMed described its service focus offers clinically managed GLP-1 programs for employers.